MedTrace Logo

Genetic Evaluation of Families With Endocrine Cancers

NCT01794676 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2017-06-16

No results posted yet for this study

Summary

This study is being conducted to identify altered genetic factors that may exist and influence endocrine cancers in unrelated MEN1 families with different cancers. A grading system will be developed for endocrine cancers, including pancreatic cancers, thymus gland cancers, parathyroid disease and MEN1 syndrome as low-risk and high-risk to improve screening and timing of surgery.

Conditions

Interventions

GENETIC

Blood draw

Blood draw

Sponsors & Collaborators

  • Rutgers University

    collaborator OTHER

  • Rutgers Cancer Institute of New Jersey

    collaborator OTHER

  • Jersey Shore University Medical Center

    lead OTHER

Principal Investigators

  • Alexander Shifrin, MD · Jersey Shore University Medical Center

Eligibility

Min Age
13 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2015-09-30
Completion
2015-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01794676 on ClinicalTrials.gov